KI-Beratung Beta

Gutscheinbedingungen

**Gültig bis 11.11.2026 auf Spielzeug, Schreibwaren, Filme, Geschenke & Trends, Musik, tolino eReader & Zubehör, Hörbücher und Hörbuch-Downloads, nicht preisgebundene Bücher und Kalender online auf thalia.at und in der Thalia App. Einzelne Artikel können ausgeschlossen sein. Aufgrund der Buchpreisbindung sind deutschsprachige Bücher und eBooks ausgenommen. Zusätzlich ausgenommen sind Abos & Flatrates, Games, Geschenkkarten/-boxen, Shelfies, Software, Zeitschriften sowie einzelne Artikel von tonies®. Pro Einkauf einmal einlösbar. Click & Collect nur bei Onlinevorabzahlung möglich. Keine Barauszahlung. Nicht kombinierbar mit anderen Aktionen und Gutscheinen. Gutschein wird auf max. 500€ Bestellwert angerechnet. Nicht gültig für Versandkosten und Services.

Produktbild: Antimicrobial Chemotherapy

Antimicrobial Chemotherapy

141,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Antimicrobial agents are essential for the treatment of life-threatening infections and for managing the burden of minor infections in the community. In addition, they play a key role in organ and bone marrow transplantation, cancer chemotherapy, artificial joint and heart valve surgery. Unlike other...

Beschreibung

Antimicrobial agents are essential for the treatment of life-threatening infections and for managing the burden of minor infections in the community. In addition, they play a key role in organ and bone marrow transplantation, cancer chemotherapy, artificial joint and heart valve surgery. Unlike other classes of medicines, they are vulnerable to resistance from mutations in target microorganisms, and their adverse effects may extend to other patients (increased risk of cross-infection). As a consequence, there is a constant requirement for new agents, as well as practices that ensure the continued effective prescribing of licensed agents. The fully revised and updated seventh edition of Antimicrobial Chemotherapy is an essential guide to the principles of antimicrobial chemotherapy, the problem of resistance and its control through policies, antimicrobial stewardship and surveillance. The book provides an aid to informed, rational prescribing for common bacterial, fungal, parasitic and viral infections. Divided in five parts, the book cover issues specific to both the developed and developing world. Part 1 'General property of antimicrobial agents' discusses mechanisms of action and resistance to antibacterial, antifungal antiprotozoal, antiviral, and antiviral agents. Part 2 'Resistance to antimicrobial agents' provides guidance about the problem of resistance, mechanisms of acquired resistance and genetics of resistance. Part 3 'General principles of usage of antimicrobial agents' analyses the use of the laboratory, general principles of the treatment of infection, dosing in special groups (extremes of age, pregnancy, obesity), safe prescribing, prophylaxis and the role of policies in antimicrobial stewardship. Part 4 'Therapeutic use of antimicrobial agents' provides advice about the treatment of common infections which are described by anatomical. There are also chapters on the management of mycobacterial disease, viral infections, HIV/AIDS and parasitic infections. The final part of the book analyses the development and marketing of antimicrobial drugs. This seventh edition of Antimicrobial Chemotherapy continues to be a valuable resource for undergraduates and graduates requiring a thorough grounding in the scientific basis and clinical application of these drugs.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

05.07.2015

Verlag Oxford University Press
Seitenzahl

430

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

05.07.2015

Verlag Oxford University Press
Seitenzahl

430

Maße (L/B/H)

24,6/16,9/2,5 cm

Gewicht

737 g

Auflage

7th Revised edition

Sprache

Englisch

ISBN

978-0-19-968977-4

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Die Leseprobe wird geladen.
  • Produktbild: Antimicrobial Chemotherapy
    • Part 1: General properties of antimicrobial agents
    • 1: Mechanisms of action and resistance to modern antibacterial with a history of their development
    • 2: Inhibitors of bacterial cell wall synthesis
    • 3: Inhibitors of bacterial protein synthesis
    • 4: Synthetic antibacterial agents and miscellaneous antibiotics
    • 5: Antiviral agents
    • 6: Antiretroviral agents
    • 7: Drugs used in the treatment of viral hepatitis
    • 8: Antifungal agents
    • 9: Antiprotozoal and anthelminthic agents
    • Part 2: Resistance to antimicrobial agents
    • 10: The problem of resistance
    • 11: The genetics and mechanisms of acquired resistance
    • Part 3: General principles of usage of antimicrobial agents
    • 12: Laboratory investigations and the treatment of infection
    • 13: General principles of the treatment of infection
    • 14: Pharmacokinetic and pharmacodynamics principles
    • 15: Prescribing in special groups: effects of age, pregnancy, body weight, hepatic and renal impairment
    • 16: Outpatient parenteral antimicrobial therapy
    • 17: Adverse drug reactions and patient safety
    • 18: Chemoprophylaxis and immunisation
    • 19: Guidelines, formularies, and antimicrobial policies
    • 20: Antimicrobial stewardship, surveillance of antimicrobial consumption and its consequences
    • Part 4: Therapeutic use of antimicrobial agents
    • 21: Respiratory tract infections
    • 22: Topical use of antimicrobial agents
    • 23: Urinary tract infections
    • 24: Sexually transmitted infections
    • 25: Gastrointestinal infections
    • 26: Serious bacterial bloodstream infections
    • 27: Bone and joint infections
    • 28: Infections of the central nervous system
    • 29: Skin and soft tissue infections
    • 30: Tuberculosis and other mycobacterial diseases
    • 31: Infections in immunocompromised patients including HIV/AIDs
    • 32: Viral infections
    • 33: Management of HIV infection
    • 34: Treatment of chronic viral hepatitis
    • 35: Parasitic disease
    • 36: The development and marketing of antimicrobial drugs
    • Appendix 1: Further Reading